Juracy Bertoldo

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

Thiago Cerqueira‐Silva, Srinivasa Vittal Katikireddi, Vinícius de Araújo Oliveira et al. · Nature Medicine · 2022 · 133 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study

Thiago Cerqueira‐Silva, Vinícius de Araújo Oliveira, Viviane Boaventura et al. · The Lancet Regional Health - Americas · 2021 · 101 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil

Thiago Cerqueira‐Silva, Vinícius de Araújo Oliveira, Enny S. Paixão et al. · Nature Communications · 2022 · 53 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study

Enny S. Paixão, Kerry LM Wong, Flávia Jôse Oliveira Alves et al. · BMC Medicine · 2022 · 32 citations · Full text

Veterinary Medicine, Infectious Diseases, Maternal Health +17

Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study

Thiago Cerqueira‐Silva, Syed Ahmar Shah, Chris Robertson et al. · PLoS Medicine · 2023 · 18 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17